Eliquis 2.5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F7VK9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,418
Award facts
- Contract value 100% obligated
- $11,417.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $11,417.76 by the Defense Logistics Agency on January 28, 2026, for the supply of Eliquis 2.5 mg tablets (60-count packages). The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 29, 2026. This delivery order is issued under Amerisourcebergen's parent company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Eliquis is an anticoagulant medication used for stroke prevention and treatment of blood clots, representing a critical pharmaceutical commodity for military and veteran healthcare systems. The Defense Logistics Agency's Troop Support Medical division procures pharmaceutical products and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This small-value delivery order exemplifies Amerisourcebergen's role as a key supplier within the federal pharmaceutical supply chain, with the company demonstrating consistent capability to fulfill diverse medical procurement requirements across multiple therapeutic domains through its competitive contract portfolio with DLA.
Quick answers
Who was awarded contract SPE2DR26F7VK9?
SPE2DR26F7VK9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F7VK9 worth?
The government has obligated $11,418 on SPE2DR26F7VK9.
Is contract SPE2DR26F7VK9 an order under another contract?
Yes. SPE2DR26F7VK9 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VK9 competed?
The extent of competition for SPE2DR26F7VK9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award